Hikma Pharmaceuticals USA INC. recalls
5 recall notices naming Hikma Pharmaceuticals USA INC. since January 2025, in United States. The most recent was published 11 Nov 2026.
Latest recalls (5)
- Hikma Pharmaceuticals USA INC. recalls Ciprofloxacin TabletsFDACGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.
- Hikma Pharmaceuticals USA INC. recalls Abirtega (abiraterone acetate) USPFDAFailed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
- Hikma Pharmaceuticals USA INC. recalls Ramipril Capsules USPFDAFailed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).
- Hikma Pharmaceuticals USA INC recalls Alendronate Sodium Oral SolutionFDAThis recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.
- Hikma Pharmaceuticals USA Inc. recalls Lorazepam InjectionFDAFailed Impurities/Degradation Specifications: An out-of-Specification for total related compounds